Ischaemic brain tissue salvaged from infarction with alteplase

Lancet

Volumn 349, Issue 9065, 1997, Pages 1599-1600

  Heiss, Wolf Dieter ^a   Grond, Martin ^b   Thiel, Alexander ^b   V Stockhausen, Hans Martin ^b   Rudolf, Jobst ^b  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0030969520     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)24022-5     Document Type: Article

References (5)

1. The National Insitute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-87.
2. ECASS. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative ECASS Study Group. JAMA 1995; 274: 1017-25.
3. Heiss W-D. Experimental evidence for ischemic thresholds and functional recovery. Stroke 1992; 23: 1668-72.
4. Powers WJ, Grubb RL Jr, Darriet D, Raichle ME. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. J Cereb Blood Flow Metab 1985; 5: 600-08.
5. Baron JC, Rougemont D, Soussaline F, et al. Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: a positron tomography study. J Cereb Blood Flow Metab 1984; 4: 140-49.